- Home
- ONTF vs RAPT Comparison
ONTF vs RAPT Comparison
Compare ONTF & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTF
- RAPT
- Stock Information
- Founded
- ONTF 1998
- RAPT 2015
- Country
- ONTF United States
- RAPT United States
- Employees
- ONTF N/A
- RAPT N/A
- Industry
- ONTF Computer Software: Prepackaged Software
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- ONTF Technology
- RAPT Health Care
- Exchange
- ONTF Nasdaq
- RAPT Nasdaq
- Market Cap
- ONTF 230.2M
- RAPT 194.2M
- IPO Year
- ONTF 2021
- RAPT 2019
- Fundamental
- Price
- ONTF $5.56
- RAPT $11.32
- Analyst Decision
- ONTF Hold
- RAPT Buy
- Analyst Count
- ONTF 4
- RAPT 5
- Target Price
- ONTF $5.33
- RAPT $33.60
- AVG Volume (30 Days)
- ONTF 162.1K
- RAPT 103.2K
- Earning Date
- ONTF 08-07-2025
- RAPT 08-07-2025
- Dividend Yield
- ONTF N/A
- RAPT N/A
- EPS Growth
- ONTF N/A
- RAPT N/A
- EPS
- ONTF N/A
- RAPT N/A
- Revenue
- ONTF $143,071,000.00
- RAPT N/A
- Revenue This Year
- ONTF N/A
- RAPT N/A
- Revenue Next Year
- ONTF N/A
- RAPT N/A
- P/E Ratio
- ONTF N/A
- RAPT N/A
- Revenue Growth
- ONTF N/A
- RAPT N/A
- 52 Week Low
- ONTF $4.35
- RAPT $5.67
- 52 Week High
- ONTF $7.04
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- ONTF 63.62
- RAPT 54.68
- Support Level
- ONTF $5.16
- RAPT $10.06
- Resistance Level
- ONTF $5.38
- RAPT $12.25
- Average True Range (ATR)
- ONTF 0.19
- RAPT 1.02
- MACD
- ONTF 0.06
- RAPT -0.05
- Stochastic Oscillator
- ONTF 98.81
- RAPT 73.29
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.